Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Eye & Contact Lens
|
January 21, 2025
Double Povidone-Iodine 5% Preparation Before Cataract Surgery for Endophthalmitis Prevention
Jamie L Odden, Jacob Winters, Leonid Zlotcavitch, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
October 30, 2010
AzaSite® inhibits Staphylococcus aureus and coagulase-negative Staphylococcus biofilm formation in vitro
Eric C Wu, Regis P Kowalski, Eric G Romanowski, et al.
Cornea
|
November 8, 2012
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection
Regis P Kowalski, Tyler A Kowalski, Robert M Q Shanks, et al.
The Ocular Surface
|
June 25, 2025
Moxifloxacin-resistant and moxifloxacin-susceptible Staphylococcus aureus Keratitis: Outcomes from a 10-year retrospective study
Raven Diacou, Rohan Bir Singh, Eric G Romanowski, et al.
Eye & Contact Lens
|
January 26, 2018
In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms
Eric G Romanowski, Nicholas A Stella, Kathleen A Yates, et al.
Antibiotics (Basel, Switzerland)
|
January 8, 2025
Efficacy of Cefiderocol Against Endophthalmitis Isolates
Brennan Schilling, Michael Hii, Hazel Q Shanks, et al.
JAMA Ophthalmology
|
March 2, 2013
Evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus
Eric G Romanowski, Kathleen A Yates, Katherine E O'Connor, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2021
Antibiotics Used in Empiric Treatment of Ocular Infections Trigger the Bacterial Rcs Stress Response System Independent of Antibiotic Susceptibility
Nathaniel S Harshaw, Nicholas A Stella, Kara M Lehner, et al.
JAMA Ophthalmology
|
October 1, 2013
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs
Regis P Kowalski, Salwa Abdel Aziz, Eric G Romanowski, et al.
Investigative Ophthalmology & Visual Science
|
November 12, 2025
Cefiderocol and Moxifloxacin Have Additive and Synergistic Activity Against Pseudomonas aeruginosa Including an Isolate of the 2023 Keratitis Outbreak
Eric G Romanowski, Brennan M Schilling, Emily K Young, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Eye & Contact Lens
|
January 21, 2025
Double Povidone-Iodine 5% Preparation Before Cataract Surgery for Endophthalmitis Prevention
Jamie L Odden, Jacob Winters, Leonid Zlotcavitch, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
October 30, 2010
AzaSite® inhibits Staphylococcus aureus and coagulase-negative Staphylococcus biofilm formation in vitro
Eric C Wu, Regis P Kowalski, Eric G Romanowski, et al.
Cornea
|
November 8, 2012
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection
Regis P Kowalski, Tyler A Kowalski, Robert M Q Shanks, et al.
The Ocular Surface
|
June 25, 2025
Moxifloxacin-resistant and moxifloxacin-susceptible Staphylococcus aureus Keratitis: Outcomes from a 10-year retrospective study
Raven Diacou, Rohan Bir Singh, Eric G Romanowski, et al.
Eye & Contact Lens
|
January 26, 2018
In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms
Eric G Romanowski, Nicholas A Stella, Kathleen A Yates, et al.
Antibiotics (Basel, Switzerland)
|
January 8, 2025
Efficacy of Cefiderocol Against Endophthalmitis Isolates
Brennan Schilling, Michael Hii, Hazel Q Shanks, et al.
JAMA Ophthalmology
|
March 2, 2013
Evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus
Eric G Romanowski, Kathleen A Yates, Katherine E O'Connor, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2021
Antibiotics Used in Empiric Treatment of Ocular Infections Trigger the Bacterial Rcs Stress Response System Independent of Antibiotic Susceptibility
Nathaniel S Harshaw, Nicholas A Stella, Kara M Lehner, et al.
JAMA Ophthalmology
|
October 1, 2013
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs
Regis P Kowalski, Salwa Abdel Aziz, Eric G Romanowski, et al.
Investigative Ophthalmology & Visual Science
|
November 12, 2025
Cefiderocol and Moxifloxacin Have Additive and Synergistic Activity Against Pseudomonas aeruginosa Including an Isolate of the 2023 Keratitis Outbreak
Eric G Romanowski, Brennan M Schilling, Emily K Young, et al.
Page
of 9